Cormorant Asset Management LP 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:13 pm Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 4,639,998 9.790% |
179,998 (+4.04%) |
Filing |
| 2021-02-16 3:06 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 4,460,000 9.970% |
1,080,630 (+31.98%) |
Filing |
| 2020-07-06 4:01 pm Purchase |
2020-06-23 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 3,379,370 8.760% |
3,379,370 (New Position) |
Filing |